CAMP and neuroblastoma: After exposure to 1 and the cAmp activator forskolin, the cAMP level in human neuroblastoma SK-N-SH changed, suggesting that the protease-resistant cyclic tetrapeptide is a potent MOR agonist with an EC50 of 2.5 nM (Fig. 7d, e).